CIK 0001347242 · <br>Emerging growth company
LIPELLA PHARMACEUTICALS INC.
Sign in to watch- Ticker
- LIPO
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 412-901-0315
- Business address
- 400 N LEXINGTON ST, STE LL103, PITTSBURGH, PA, 15208
- Former names
- LIPELLA PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-15 | Pruchnic Ryan Director | Grant or award · Stock Options | +25,000 | 25,000 | ||
| 2024-03-15 | Yoshimura Naoki Director | Grant or award · Stock Options | +25,000 | 25,000 | ||
| 2024-03-15 | Chancellor Michael B Chief Medical Officer | Grant or award · Stock Options | +80,000 | 80,000 | ||
| 2024-03-15 | Birder Lori Director | Grant or award · Stock Options | +25,000 | 25,000 | ||
| 2024-03-15 | Kaufman Jonathan H See remarks below. | Grant or award · Stock Options | +80,000 | 80,000 | ||
| 2024-03-15 | Johnston Douglas Chief Financial Officer | Grant or award · Stock Options | +50,000 | 50,000 | ||
| 2024-03-15 | Cohen Daniel R Director | Grant or award · Stock Options | +25,000 | 25,000 | ||
| 2024-03-15 | Kim Byong Director | Grant or award · Stock Options | +25,000 | 25,000 | ||
| 2024-03-13 | Kaufman Jonathan H See remarks below. | Grant or award | +144,906 | $0.69 | $100K | 833,849 |
| 2024-03-13 | Chancellor Michael B Chief Medical Officer | Grant or award | +144,906 | $0.69 | $100K | 877,637 |
| 2023-06-16 | Cohen Daniel R Director | Grant or award · Stock Options | +25,000 | 25,000 | ||
| 2023-06-16 | Battleman David S. Director | Grant or award · Stock Options | +25,000 | 25,000 | ||
| 2023-06-16 | Pruchnic Ryan Director | Grant or award · Stock Options | +25,000 | 25,000 | ||
| 2023-06-16 | Kaufman Jonathan H See remarks below. | Grant or award · Stock Options | +79,500 | 79,500 | ||
| 2023-06-16 | Chancellor Michael B Chief Medical Officer | Grant or award · Stock Options | +79,500 | 79,500 | ||
| 2023-06-16 | Yoshimura Naoki Director | Grant or award · Stock Options | +25,000 | 25,000 | ||
| 2023-06-16 | Kim Byong Director | Grant or award · Stock Options | +25,000 | 25,000 | ||
| 2023-06-16 | Johnston Douglas Chief Financial Officer | Grant or award · Options to Purchase | +50,000 | 50,000 | ||
| 2022-12-22 | Chancellor Michael B Chief Medical Officer | Other acquisition | +22,950 | $5.75 | $132K | 732,730 |
Page 2 of 2 · 39 trades